Identifying patients with therapy-resistant depression by using factor analysis

Pharmacopsychiatry

Volumn 43, Issue 7, 2010, Pages 252-256

  Andreasson, K ^a   Liest, V ^b   Lunde, M ^a   Martiny, K ^a   Unden, M ^c   Dissing, S ^a   Bech, P ^a  

^a FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

^b Hogland Hospital   (Sweden)

^c University of Copenhagen ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DULOXETINE; ESCITALOPRAM; LITHIUM DERIVATIVE; MIRTAZAPINE; MOOD STABILIZER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CONCENTRATION LOSS; FACTORIAL ANALYSIS; FEMALE; HUMAN; LASSITUDE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSED ELECTRIC FIELD; RATING SCALE; SLEEP DISORDER; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; PLACEBOS; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 78049434578     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1263166     Document Type: Article

References (29)

1. Allerup P. Statistical analysis of rating scales. Danish Institute of Educational Research, Copenhagen 1986
2. Avery DH, Holtheimer PE, Fowaz W, et al. Controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2005 59 187-194
3. Bagby RM, Ryder AG, Schiller DR, et al. The Hamilton depression rating scale: has the gold standard become a lead weight? Am J Psychiatry 2004 161 2163-2177
4. Bech P, Allerup P, Gram LF, et al. The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981 63 290-299
5. Bech P, Allerup P, Reisby N, et al. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants. Psychopharmacology 1984 84 276-281
6. Bech P, Allerup P, Maier W, et al. The Hamilton scales and the Hopkins symptom checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry 1992 160 206-211
7. Bech P. The Bech, Hamilton and Zung scales for mood disorders: screening and listening. Springer Berlin. 2nd Edn 1996
8. Bech P. Applied psychometrics in clinical psychiatry: The pharmacopsychometric triangle. Acta Psychiatr Scand 2009 120 400-409
9. Bretlau LG, Lunde M, Lindberg L, et al. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression. A double-blind, randomised, sham-controlled trial. Pharmacopsychiatry 2008 41 41-47
10. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric application of transcranial magnetic stimulation: a metaanalysis. Int J Neuropsychopharmacol 2002 5 73-103
11. Child D. The Essentials of Factor Analysis. 3rd Edn. Cassel Educational, London 2006
12. Fekadu A, Wooderson S, Donaldson C. A multidimensional tool for quantifying treatment resistance to depression: The Maudsley staging method. J Clin Psychiatry 2009 70 177-184
13. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967 6 278-296
14. Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry 1969 Special publ 76-79
15. Hamilton M. Clinical evaluation of depressions: Clinical criteria and rating scales, including a Guttman Scale. In Gallant DM, Simpson GA (eds). Depression: Behavioural, biochemical, diagnosis and treatment concepts. New York, Spectrum Publication 1976 155-179
16. Kline P. The handbook of psychological testing. London, Routledge 1993
17. Kørner A, Nielsen BM, Eschen F, et al. Quantifying depressive symptomatology: inter-rater reliability and inter-item correlations. J Affec Dis 1990 20 143-149
18. Lauritzen L, Odgaard K, Clemmesen L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996 94 241-251
19. Licht RW, Qvitzau S, Allerup P, et al. Validation of the Bech-Rafaelsen melancholia scale and the Hamilton depression scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005 111 144-149
20. Marli GS, Parker GB, Greenwood J. Structural and functional models of depression: from sub-types to substrates. Acta Psychiatr Scand 2005 111 94-105
21. Martiny K, Lunde M, Bech P. Controlled study of pulsed magnetic fields (PEMF) in medication-resistant major depression. Eur Neuropsychopharmalogy 2009 19 478
22. Martiny K, Lunde M, Bech P. Transcranial low voltage pulsed electromagnetic fields (T-PEMF) in patients with treatment-resistant depression. Biological Psychiatr 2010 68 163-169
23. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 382-389
24. Nolen WA, Zohar J, Roose SP. (Eds). Refractory depression. Current strategies and future directions. Chichester, John Wiley 1994
25. Parker GB, Malhi GS, Crawford JG, et al. Identifying paradigm failures contributing to treatment resistant depression. J Affect Disord 2005 87 185-191
26. Paykel ES. Achieving gains beyond response. Acta Psychiatr Scand 2002 106 Suppl. 415 12-17
27. Rahbek UL, Tritsaris K, Dissing S. Interactions of low frequency, pulsed electromagnetic fields with living tissue: biochemical responses and clinical results. Oral Biosci Med 2005 2 29-40
28. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001 62 Suppl. 16 10-17
29. Uher R, Farmer A, Maier W. Measuring depression: comparison and integration of three scales in GENDEP-study. Psychol Med 2008 289-300